Health Economics and Policy

You might want to do the right thing and get stuck in – but there’s a bigger picture to be seen before you do.

“In Conversation With...”, an ongoing series of informal interviews with some of the biggest personalities in ophthalmology in glorious settings around the globe.

The Greek bailouts came with a price: austerity. This might come to pass as a highly myopic move. We explore its impact on ophthalmology – and the future health economic toll it will take on Greek society.

The rise of the experience economy means that ophthalmology practices must go to great lengths to ensure their patients are receiving not just the best medical care, but also the best possible customer service

Gene and stem cell therapies hold the promise of restoring vision in patients with retinal diseases – but who should be paying for these treatments, and how?

We look at the last 50 years of Fight for Sight – the projects it has funded, and the discoveries its funding helped to achieve.

Ophthalmologists and other eye health stakeholders lobby UK Parliament to implement improved sight loss and eye health services

Italy reimburses off-label bevacizumab use in ophthalmology – pharma complains to the European Commission.

New testing methods could help eliminate the neglected tropical disease

Peek Retina is an adaptor for your smartphone that promises easy and high-quality fundoscopy – no matter if you’re in Scotland or sub-Saharan Africa